$23.33
arrow_drop_down4.54%Key Stats | |
---|---|
Open | $24.76 |
Prev. Close | $24.69 |
EPS | -2.90 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 24.35 | 25.11 |
52 Week Range | 4.22 | 26.12 |
Ratios | |
---|---|
EPS | -2.90 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)
Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights